HILDA SOLIS: Open Payments
NPI 1154340719 · PHARR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,882 in 21 payments from 11 companies in 2025. Trend: 2023 $1,671 · 2024 $1,554 · 2025 $1,882
Food & beverage: $1,771Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $387 |
| Teva Pharmaceuticals USA, Inc. | 3 | $252 |
| ABBVIE INC. | 2 | $250 |
| E.R. Squibb & Sons, L.L.C. | 3 | $208 |
| Lilly USA, LLC | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| KYOWA KIRIN, INC. | 1 | $125 |
| ViiV Healthcare Company | 1 | $121 |
| Neurocrine BioSciences, Inc. | 1 | $119 |
| AstraZeneca Pharmaceuticals LP | 1 | $93 |
Products named: REXULTI, VRAYLAR, COBENFY, VOQUEZNA, ABILIFY MAINTENA, APRETUDE, INGREZZA, UZEDY.
Industry payments across TX — which companies pay providers there.
